ITGDF (Integral Diagnostics) Interest Expense: $-16.3 Mil (TTM As of Dec. 2025)

What is Integral Diagnostics Interest Expense?

Integral Diagnostics ITGDF 73 Interest Expense is $-16.3 Mil as of Dec. 2025. GuruFocus rates ITGDF with a GF Score™ of 73/100 and a GF Value™ of $1.39. The stock has 9 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Integral Diagnostics's interest expense for the six months ended in Dec. 2025 was $ -11.2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was $-16.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Integral Diagnostics's Operating Income for the six months ended in Dec. 2025 was $ 22.1 Mil. Integral Diagnostics's Interest Expense for the six months ended in Dec. 2025 was $ -11.2 Mil. Integral Diagnostics's Interest Coverage for the quarter that ended in Dec. 2025 was 1.97. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Integral Diagnostics (OTCPK:ITGDF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Integral Diagnostics's Interest Expense for the six months ended in Dec. 2025 was $-11.2 Mil. Its Operating Income for the six months ended in Dec. 2025 was $22.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was $386.5 Mil.

Integral Diagnostics's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2025 )	/	Interest Expense (Q: Dec. 2025 )
	=	-1	*	22.134	/	-11.209
	=	1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Integral Diagnostics Ltd interest coverage is 2.86, which is low.

Integral Diagnostics Interest Expense Historical Data

* Premium members only.

The historical data trend for Integral Diagnostics's Interest Expense can be seen below:

Integral Diagnostics Interest Expense Chart

Integral Diagnostics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Interest Expense

Get a 7-Day Free Trial

-6.81

-7.37

-12.33

-11.29

-12.70

Integral Diagnostics Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Interest Expense	Get a 7-Day Free Trial															-7.64	-3.71	-7.42	-5.07	-11.21

73GF Score

Integral Diagnostics Ltd ITGDF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Integral Diagnostics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-16.3 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-16.3 Mil mean?

Integral Diagnostics (ITGDF) has a Interest Expense of $-16.3 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Integral Diagnostics and its competitors.

Is Integral Diagnostics' Interest Expense too high?

Integral Diagnostics' current Interest Expense is $-16.3 Mil. Overall, Integral Diagnostics has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.

How does Integral Diagnostics' Interest Expense compare to TMO and DHR?

Integral Diagnostics' Interest Expense of $-16.3 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Diagnostics & Research company?

A good Interest Expense depends on the Medical Diagnostics & Research industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Integral Diagnostics and its competitors. Integral Diagnostics's current Interest Expense is $-16.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Integral Diagnostics stock overvalued right now?

Integral Diagnostics (ITGDF) has a current Interest Expense of $-16.3 Mil. The stock's GF Value™ is $1.39, compared to a current price of $2.61 — trading 87.9% above its estimated fair value. The current Interest Expense is $-16.3 Mil. Integral Diagnostics' overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Integral Diagnostics (ITGDF), the current Interest Expense is $-16.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integral Diagnostics (ITGDF) Overvalued in 2026?

Based on GuruFocus' analysis, Integral Diagnostics stock appears to be overvalued. The current stock price of $2.61 is trading 87.9% above its estimated GF Value™ of $1.39.

Key valuation signals for ITGDF:

Interest Expense: $-16.3 Mil
GF Value™: $1.39 vs. price of $2.61 (87.9% above fair value)
GF Score™: 73/100 with 9 warning signs

No single metric tells the full story. See the ITGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integral Diagnostics Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies ASX:ACL ASX:MVF ASX:HLS ASX:IIQ ASX:CTE ASX:RHY ASX:BDX ASX:MAP ASX:IME ASX:GSS TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN

Other Exchanges IDX:Australia

Address 288 Victoria Parade, Level 2, Melbourne, VIC, AUS, 3002

Website https://www.integraldiagnostics.com.au

Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.

73GF Score

Get the complete analysis for ITGDF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.61

Price

$1.39

GF Value

View ITGDF Analysis

See Interest Expense data for all stocks →